0001708138-20-000082.txt : 20200702 0001708138-20-000082.hdr.sgml : 20200702 20200702160220 ACCESSION NUMBER: 0001708138-20-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL S CENTRAL INDEX KEY: 0001174475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201009191 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-07-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001174475 BROWN MICHAEL S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-07-01 4 M 0 3613 413.33 A 4256 D Common Stock 2020-07-01 4 S 0 100 601.7 D 4156 D Common Stock 2020-07-01 4 S 0 627 603.39 D 3529 D Common Stock 2020-07-01 4 S 0 960 604.82 D 2569 D Common Stock 2020-07-01 4 S 0 401 605.78 D 2168 D Common Stock 2020-07-01 4 S 0 319 608.59 D 1849 D Common Stock 2020-07-01 4 S 0 200 609.51 D 1649 D Common Stock 2020-07-01 4 S 0 100 615.23 D 1549 D Common Stock 2020-07-01 4 S 0 200 616.49 D 1349 D Common Stock 2020-07-01 4 S 0 100 623.07 D 1249 D Common Stock 2020-07-01 4 S 0 6 624.19 D 1243 D Common Stock 2020-07-01 4 S 0 200 607.35 D 1043 D Common Stock 2020-07-01 4 S 0 400 612.29 D 643 D Common Stock 5000 I by SLAT Common Stock 11349 I by Trust Non-Qualified Stock Option (right to buy) 413.33 2020-07-01 4 M 0 3613 0.0 D 2025-01-02 Common Stock 3613 7225 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 627 shares of Company stock on July 1, 2020 at prices ranging from $602.95 to $603.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 960 shares of Company stock on July 1, 2020 at prices ranging from $604.16 to $605.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 401 shares of Company stock on July 1, 2020 at prices ranging from $605.25 to $606.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 319 shares of Company stock on July 1, 2020 at prices ranging from $608.14 to $609.12. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on July 1, 2020 at prices ranging from $609.22 to $609.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on July 1, 2020 at prices ranging from $607.10 to $607.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on July 1, 2020 at prices ranging from $612.21 to $612.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2020 at each separate price. These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Michael S. Brown 2020-07-02